
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC fell 35.1% from $0.51 to $0.33, behind the S&P 500's +4.7%. Its worst day was Jul 16 (−27.2%), and its low came Jul 28 at $0.30.
Nov 21, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC closed at its highest level of the year, 0.6% above where the year started.
+0.6% · S&P 500 +1.5%
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC shares rose 29.5%, while the S&P 500 rose 0.4%.
Story events cover the past 12 months · Times ET
+29.5%, the year's best day · S&P 500 +0.4%
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC closed at its lowest level of the year, 41.0% below where the year started.
−11.4% · S&P 500 +0.2%
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC shares rose 22.9%, while the S&P 500 fell 0.7%.
+22.9%, on 165K shares, the year's heaviest volume · S&P 500 −0.7%
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC shares rose 17.6%, while the S&P 500 fell 0.3%.
+17.6% · S&P 500 −0.3%
Where it ended: a close of $0.33 on Nov 20, 2026.
Nothing in the past 12 months.
All NRXBF earningsNothing in the past 12 months.
All NRXBF analyst actionsNothing in the past 12 months.
All NRXBF dividend history